Browse by Poster Presenter

Schedule at a Glance

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Browse by Poster Presenter

Type here to filter the list

N
Nacev, Benjamin

University of Pittsburgh Hillman Cancer Center
(P 373) DEDIFFERENTIATED AND HIGH GRADE CHONDROSARCOMAS: HOW DOES ISOCITRATE DEHYDROGENASE STATUS APPRISE PROGNOSIS AND THERAPY?
Benjamin Nacev
Favorite
Nachankar, Ankita

MedAustron Ion therapy Center, Austria
(P 326) CARBON-ION RADIOTHERAPY FOR UNRESECTABLE PELVIC SARCOMAS/CHORDOMAS
Ankita Nachankar
Favorite
Nadesan, Puviindran

Duke University
(P 393) INVESTIGATING THE ROLE OF HDACS IN THE PROGRESSION OF METASTATIC UNDIFFERENTIATED PLEOMORPHIC SARCOMA
Puviindran Nadesan
Favorite
Nagarkar, Ritika

University College London
(P 519) WHAT ARE THE EXPERIENCES OF GAIT, ACTIVITY LEVELS AND PHYSICAL FUNCTIONING IN PROXIMAL FEMORAL REPLACEMENT AFTER MUSCULOSKELETAL TUMORS?
Ritika Nagarkar
Favorite
Nagasawa, Hiroyuki

Akita University Graduate School of Medicine
(P 05) COEFFICIENT OF VARIATION OF T2-WEIGHTED MRI PREDICTS THE PROGNOSIS OF MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Hiroyuki Nagasawa
Favorite
(P 469) IMPACT OF A SPECIALIZED OUTPATIENT CLINIC ON BONE MRTASTASIS AND ITS BURDEN ON SPINE SURGEONS
Hiroyuki Nagasawa
Favorite
(P 470) PROGNOSTIC SIGNIFICANCE OF HISTOLOGICAL SUBTYPE IN SOFT TISSUE SARCOMA WITH DISTANT METASTASIS
Hiroyuki Nagasawa
Favorite
(P 471) IMPACT OF PRIMARY TUMOR RESECTION ON METASTASIS TO THE LUNG IN PATIENTS WITH BONE AND SOFT-TISSUE SARCOMA
Hiroyuki Nagasawa
Favorite
(P 486) PRIMARY HIGH-GRADE SARCOMA OF THE SPINE: EXPERIENCE WITH 11 CASES
Hiroyuki Nagasawa
Favorite
Nagasubramanian, Ramamoorthy

Nemours Children's Hospital
(P 161) EFFICACY, SAFETY, AND TREATMENT HOLD WAIT-AND-SEE OUTCOMES OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION SARCOMAS
Ramamoorthy Nagasubramanian
Favorite
Nagulapally, Abhinav

Atrium Health Levine Children's Hospital
(P 266) ROMIDEPSIN DECREASES DNA DAMAGE REPAIR AND INCREASES SENSITIVITY TO CHEMOTHERAPY IN EWING SARCOMA
Abhinav Nagulapally
Favorite
Nakagawa, Makoto

Duke University
(P 72) CO-EXPRESSION OF LEUKOCYTE CYTOSOLIC PROTEIN 1 AND MATRIX METALLOPROTEINASES ARE INTEGRAL FOR METASTATIC PROGRESSION OF CHONDROSARCOMA
Makoto Nakagawa
Favorite
(P 375) IDENTIFICATION OF METASTATIC CELLS IN UNDIFFERENTIATED PLEOMORPHIC SARCOMA: SINGLE CELL RNA SEQUENCING AND CIBERSORT ANALYSIS
Makoto Nakagawa
Favorite
Nakagawa, Suely

AC Camargo Cancer Center
(P 192) ROLE OF MAGNETIC RESONANCE IMAGING IN THE PREDICTION OF HISTOLOGICAL GRADE IN SOFT TISSUE SARCOMAS.
Suely Nakagawa
Favorite
Nakagawa, Wilson

AC Camargo Cancer Center
(P 192) ROLE OF MAGNETIC RESONANCE IMAGING IN THE PREDICTION OF HISTOLOGICAL GRADE IN SOFT TISSUE SARCOMAS.
Wilson Nakagawa
Favorite
Nakahashi, Naoya

Sapporo Medical University School of Medicine
(P 05) COEFFICIENT OF VARIATION OF T2-WEIGHTED MRI PREDICTS THE PROGNOSIS OF MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Naoya Nakahashi
Favorite
(P 391) THE EXPRESSION OF PVR AND ITS CLINICOPATHOLOGICAL SIGNIFICANCE IN MPNST.
Naoya Nakahashi
Favorite
(P 486) PRIMARY HIGH-GRADE SARCOMA OF THE SPINE: EXPERIENCE WITH 11 CASES
Naoya Nakahashi
Favorite
Nakai, Sho

Osaka International Cancer Institute
(P 05) COEFFICIENT OF VARIATION OF T2-WEIGHTED MRI PREDICTS THE PROGNOSIS OF MALIGNANT PERIPHERAL NERVE SHEATH TUMOR
Sho Nakai
Favorite
Nakamura, Kenichi

National Cancer Center Hospital
(P 10) ATEZOLIZUMAB IN JAPANESE PATIENTS WITH ADVANCED ALVEOLAR SOFT PART SARCOMA: A MULTI-CENTER, SINGLE-ARM, INVESTIGATOR-INITIATED PHASE 2 TRIAL (NCCH1907)
Kenichi Nakamura
Favorite
Nakashima, Yasuharu

Department of Orthopaedic Surgery, Graduate School of Medical Sciences, Kyushu University
(P 406) EXTENSIVE ANALYSIS OF 59 SARCOMA-RELATED FUSION GENES IDENTIFIED PAZOPANIB AS A POTENTIAL INHIBITOR TO COL1A1-PDGFB FUSION GENE
Yasuharu Nakashima
Favorite
Nakata, Eiji

Okayama University Hospital
(P 16) ALVEOLAR SOFT PART SARCOMA: PROGRESS TOWARD IMPROVEMENT IN SURVIVAL? A NATIONWIDE DATABASE STUDY IN JAPAN
Eiji Nakata
Favorite
Nakayama, Robert

Department of Orthopaedic Surgery, Keio University School of Medicine
(P 396) COMPREHENSIVE WHOLE-GENOME MOLECULAR PROFILING IN BONE AND SOFT TISSUE SARCOMA: MULTI-OMICS ANALYSIS OF 627 CASES ACROSS HISTOLOGIC SUBTYPES
Robert Nakayama
Favorite
Nakazawa, Michael

MD Anderson Cancer Center
(P 360) TP53 ALTERATIONS IN SARCOMAS: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Michael Nakazawa
Favorite
Nakken, Sigve

Oslo University Hospital
(P 23) GENOMIC COMPLEXITY AS A BIOMARKER FOR ADJUVANT IMATINIB TREATMENT IN HIGH-RISK GASTROINTESTINAL STROMAL TUMOR
Sigve Nakken
Favorite
Namløs, Heidi

Oslo University Hospital
(P 23) GENOMIC COMPLEXITY AS A BIOMARKER FOR ADJUVANT IMATINIB TREATMENT IN HIGH-RISK GASTROINTESTINAL STROMAL TUMOR
Heidi Namløs
Favorite
Nannini, Margherita

IRCSS Azienda Ospedaliero-Universitaria di Bologna
(P 27) A MULTICENTER RETROSPECTIVE STUDY ON THE CLINICAL BEHAVIOR OF SDH-DEFICIENT GIST
Margherita Nannini
Favorite
Napier, Christine

Garvan Institute of Medical Research
(P 386) GENOMIC PROFILING OF GYNAECOLOGICAL SARCOMAS: REPORT FROM THE AUSTRALIA-WIDE PRECISION ONCOLOGY PROGRAM
Christine Napier
Favorite
Napoli, Francesca

Department of Oncology, University of Turin
(P 262) ESTABLISHMENT AND CHARACTERIZATION OF THE FIRST RADIATION-INDUCED, PATIENT-DERIVED ANGIOSARCOMA CELL LINE
Francesca Napoli
Favorite
Napolitano, Andrea

The Royal Marsden NHS, London, UK
(P 49) EFFICACY OF RIPRETINIB IN A MULTICENTER EXPANDED ACCESS PROGRAM IN PATIENTS WITH ADVANCED GASTROINTESTINAL STROMAL TUMORS HARBOURING NON-KIT EXON 11 MUTATIONS.
Andrea Napolitano
Favorite
(P 189) INTERNATIONAL RETROSPECTIVE STUDY FROM THE ULTRA-RARE SARCOMA WORKING GROUP ON LOW-GRADE FIBROMYXOID SARCOMA AND SCLEROSING EPITHELIOD FIBROSARCOMA: OUTCOME OF ADVANCED DISEASE AND SYSTEMIC THERAPIES
Andrea Napolitano
Favorite
Nara, Satoshi

Department of Hepatoibiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan
(P 332) SURGICAL OUTCOMES OF RETROPERITONEAL LIPOSARCOMA - SINGLE INSTITUTIONAL STUDY N JAPAN -
Satoshi Nara
Favorite
Narasimhan, Supraja

Deciphera Pharmaceuticals, LLC
(P 173) SAFETY, EFFICACY, AND PATIENT-REPORTED OUTCOMES WITH VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR WHO RECEIVED PRIOR ANTI–COLONY-STIMULATING FACTOR 1 THERAPY: ONGOING PHASE 2 UPDATE
Supraja Narasimhan
Favorite
(P 176) SAFETY, EFFICACY, AND PATIENT-REPORTED OUTCOMES WITH VIMSELTINIB IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR WHO RECEIVED NO PRIOR ANTI–COLONY-STIMULATING FACTOR 1 THERAPY: ONGOING PHASE 2 UPDATE
Supraja Narasimhan
Favorite
Nardi, Walter

Buenos Aires British Hospital
(P 460) IMPACT OF RESIDUAL TUMOR AFTER RE-EXCISION IN PATIENTS WITH PRIOR UNPLANNED RESECTION OF EXTREMITY AND TRUNK SOFT TISSUE SARCOMAS
Walter Nardi
Favorite
Nardo, Lorenzo

University of California Davis Health
(P 233) MULTI-CENTER EXTERNAL VALIDATION OF AN AUTOMATED MODEL DIFFERENTIATING ALT FROM LIPOMA USING RADIOMICS AND DEEP-LEARNING BASED SEGMENTATION
Lorenzo Nardo
Favorite
Narducci, Nadine

Department of Medicine, University of Padua School of Medicine, Padova, Italy
(P 378) MULTIOMICS PROFILING OF EPITHELIOID SARCOMA UNVEILS EPIGENETIC CIRCUITRIES THAT UNDERLIE THE PATHOBIOLOGY OF PROXIMAL AND CLASSIC SUBTYPES: RESULTS FROM THE ISG EPISOBS OBSERVATIONAL STUDY
Nadine Narducci
Favorite
Nargizyan, Anahit

Children's Hospital Los Angeles
(P 430) UNIQUE HISTOLOGIC MORPHOLOGY OF EWING SARCOMA CELLS THAT HARBOR TP53 MUTATIONS
Anahit Nargizyan
Favorite
Nascimento, Antonio

AC Camargo Cancer Center
(P 192) ROLE OF MAGNETIC RESONANCE IMAGING IN THE PREDICTION OF HISTOLOGICAL GRADE IN SOFT TISSUE SARCOMAS.
Antonio Nascimento
Favorite
Nash, Joshua

The Hospital for Sick Children
(P 260) TARGETING HOMOLOGOUS RECOMBINATION DEFICIENCY (HRD) IN LEIOMYOSARCOMA WITH COMBINATION OF PARP INHIBITORS (PARPI) AND CHEMOTHERAPY (CTX).
Joshua Nash
Favorite
(P 421) USING TRANSCRIPTOMICS TO IDENTIFY LEIOMYOSARCOMA PATIENTS AT RISK OF METASTASIS
Joshua Nash
Favorite
Nassif, Elise

University of Texas MD Anderson Cancer Center
(P 71) CHEMOTHERAPY AND PROGNOSTIC SIGNIFICANCE OF EXTENT OF DEDIFFERENTIATION IN DEDIFFERENTIATED PAROSTEAL OSTEOSARCOMA
Elise Nassif
Favorite
(P 100) HISTOLOGY SPECIFIC INTRATUMORAL B-CELL BIOLOGY IN ALVEOLAR SOFT-PART SARCOMAS (ASPS) IN RESPONSE TO DURVALUMAB-TREMELIMUMAB (D-T)
Elise Nassif
Favorite
(P 123) DEDIFFERENTIATED LIPOSARCOMAS TREATED WITH IMMUNE CHECKPOINT BLOCKADE: THE MD ANDERSON EXPERIENCE
Elise Nassif
Favorite
(P 360) TP53 ALTERATIONS IN SARCOMAS: AN ANALYSIS FROM THE AACR-GENIE DATABASE
Elise Nassif
Favorite
Nassif, Elise

MD Anderson Cancer Center
(P 394) LEIOMYOSARCOMA INTRATUMORAL MACROPHAGE INFILTRATES ARE ASSOCIATED WITH DISTINCT CLINICAL AND GENOMIC PRESENTATIONS
Elise Nassif
Favorite
Nathenson, Michael

Adaptimmune
(P 114) PRIMARY ANALYSIS OF EFFICACY AND SAFETY OF LETETRESGENE AUTOLEUCEL (LETE-CEL) AS FIRST-LINE TREATMENT FOR UNRESECTABLE OR METASTATIC SYNOVIAL SARCOMA (SS); SUBSTUDY 1 OF IGNYTE-ESO
Michael Nathenson
Favorite
Nathrath, Michaela

Klinikum Kassel
(P 230) SARCDBASE: A TOOL FOR DETECTION OF GENETIC ALTERATIONS IN SARCOMA
Michaela Nathrath
Favorite
(P 371) DISRUPTION OF THE TP53 LOCUS IN OSTEOSARCOMA LEADS TO TP53 PROMOTER GENE FUSIONS AND RESTORATION OF PARTS OF THE TP53 SIGNALLING PATHWAY
Michaela Nathrath
Favorite
Navarria, Pierina

IRCCS Humanitas Research Hospital
(P 327) LEARNING CURVE ANALYSIS IN RETROPERITONEAL SARCOMA SURGERY
Pierina Navarria
Favorite
Navarria, Pierina

Humanitas Research Hospital
(P 433) A 20-YEAR MONOCENTER EXPERIENCE ON CLINICAL CHARACTERISTICS AND OUTCOME OF EXTRASKELETAL EWING SARCOMA.
Pierina Navarria
Favorite
Navarria, Pierina

IRCCS Humanitas Research Hospital
(P 457) LONG-TERM FOLLOW-UP OF PATIENTS WITH ATYPICAL LIPOMATOUS TUMOR (ALT) TREATED WITH MARGINAL RESECTION IN A REFERRAL CENTER
Pierina Navarria
Favorite
Navarro, Willis

Aadi Bioscience
(P 540) PHASE 2, MULTICENTER, OPEN-LABEL BASKET TRIAL OF NAB-SIROLIMUS FOR MALIGNANT SOLID TUMORS HARBORING PATHOGENIC INACTIVATING ALTERATIONS IN TSC1 AND TSC2 (PRECISION I)
Willis Navarro
Favorite
Navas, Ana

Leiden University Medical Center
(P 56) CHARACTERIZATION OF DENOSUMAB TREATMENT RESPONSE ON MR PERFUSION IN GIANT CELL TUMORS OF BONE
Ana Navas
Favorite
Navid, Fariba

Children’s Hospital Los Angeles
(P 166) SARC038: A PHASE 2 STUDY OF REGORAFENIB IN COMBINATION WITH NIVOLUMAB IN PATIENTS WITH REFRACTORY OR RECURRENT OSTEOSARCOMA
Fariba Navid
Favorite
(P 430) UNIQUE HISTOLOGIC MORPHOLOGY OF EWING SARCOMA CELLS THAT HARBOR TP53 MUTATIONS
Fariba Navid
Favorite
(P 556) EVALUATION OF PALBOCICLIB (IBRANCE®) IN COMBINATION WITH CHEMOTHERAPY IN PEDIATRIC PATIENTS WITH RECURRENT OR REFRACTORY EWING SARCOMA OR NEUROBLASTOMA
Fariba Navid
Favorite
Nazaretian, Ashot

Fox Chase Cancer Center
(P 287) ESTABLISHMENT AND GENOMIC VALIDATION OF NOVEL PATIENT-DERIVED XENOGRAFT MODELS FOR DRUG DISCOVERY IN GASTROINTESTINAL STROMAL TUMOR
Ashot Nazaretian
Favorite
Nazon, Charlotte

University Hospital of Strasbourg
(P 277) ANTI-GD2 SYNERGIZES WITH HYPOXIA PATHWAY TARGETING TO BLOCK OSTEOSARCOMA CELL PROLIFERATION AND MIGRATION.
Charlotte Nazon
Favorite
Ndengu, Andoyo

Memorial Sloan Kettering Cancer Center
(P 289) IDENTIFICATION OF EFFECTIVE THERAPEUTIC COMBINATIONS WITH THE NUCLEAR EXPORT PROTEIN INHIBITOR, SELINEXOR, IN PEDIATRIC SOLID TUMORS
Andoyo Ndengu
Favorite
Ndounga-Diakou, Lee Aymar

Gustave Roussy Cancer Campus
(P 75) REAL-WORLD DATA ON REGORAFENIB AND CABOZANTINIB IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH RELAPSED OSTEOSARCOMA AND EWING SARCOMA INCLUDED IN THE SACHA-FRANCE STUDY
Lee Aymar Ndounga-Diakou
Favorite
Neal, Audrey

Clear Cell Sarcoma Foundation
(P 20) CLEAR CELL SARCOMA: PATIENT REPORTED REAL WORLD EVIDENCE
Audrey Neal
Favorite
Neal, Jill

Clear Cell Sarcoma Foundation
(P 20) CLEAR CELL SARCOMA: PATIENT REPORTED REAL WORLD EVIDENCE
Jill Neal
Favorite
Nebchi, Souad

Gustave Roussy cancer Centre
(P 212) REPORT ON THE EWING SARCOMA PATIENTS ENROLLED IN ARM D OF THE ACSE-ESMART TRIAL: PHASE I/II STUDY OF THE PARP INHIBITOR OLAPARIB IN COMBINATION WITH IRINOTECAN IN CHILDREN WITH ADVANCED MALIGNANCIES
Souad Nebchi
Favorite
Neben-Wittich, Michelle

Mayo Clinic Minnesota
(P 312) MANAGEMENT OF ADULT HEAD AND NECK SOFT TISSUE SARCOMA: THE MAYO CLINIC EXPERIENCE
Michelle Neben-Wittich
Favorite
Neilson, John

Medical College of Wisconsin
(P 181) REAL-WORLD EXPERIENCE WITH LIPOSOMAL DOXORUBICIN IN METASTATIC AND LOCALLY ADVANCED SARCOMA
John Neilson
Favorite
(P 473) GROIN PAINS: APPROACHES AND OUTCOMES FOR INGUINOFEMORAL SOFT TISSUE SARCOMAS
John Neilson
Favorite
Nelson, C.

Huntsman Cancer Institute/University of Utah
(P 412) LEIOMYOSARCOMA POLYANEUPLOID CANCER CELLS DEVELOP IN RESPONSE TO CHEMOTHERAPY AND CONTRIBUTE TO CHEMORESISTANCE
C. Nelson
Favorite
Nelson, Marie

Children's National Hospital
(P 18) RETROSPECTIVE ANALYSIS ON OUTCOMES PEDIATRIC PATIENTS WITH SARCOMA AND LUNG METASTASES STATUS POST PNEUMONECTOMY VERSUS PARTIAL LUNG RESECTION
Marie Nelson
Favorite
Nessim, Carolyn

Department of Surgery, University of Ottawa
(P 152) EVALUATING DIAGNOSTIC APPROACHES TO DERMATOFIBROSARCOMA PROTUBERANS: AN OPPORTUNITY TO REDUCE THE NUMBER OF INTERVENTIONS
Carolyn Nessim
Favorite
(P 215) IMPACT OF FRONTLINE SYSTEMIC TREATMENT CHOICE ON CLINICAL OUTCOME IN ADVANCED LEIOMYOSARCOMA: A MULTI-CENTRE RETROSPECTIVE CANSARCC STUDY
Carolyn Nessim
Favorite
(P 342) THE EVALUATION AND OUTCOMES OF MESENTERIC AND INTRA-ABDOMINAL DESMOIDS: A TARPSWG STUDY
Carolyn Nessim
Favorite
Nester, Matthew

University of South Florida Morsani College of Medicine
(P 511) SIGNIFICANCE OF TIP TO APEX DISTANCE IN PATHOLOGICAL AND IMPENDING PATHOLOGICAL FRACTURES OF THE PROXIMAL FEMUR
Matthew Nester
Favorite
Neville, Kathleen

C4 Therapeutics
(P 178) INITIAL RESULTS FROM A PHASE 1 STUDY OF CFT8634, A NOVEL BIFUCTIONAL DEGRADATION ACTIVATING COMPOUND (BIDAC) DEGRADER OF BRD9, IN SYNOVIAL SARCOMA AND SMARCB1-NULL TUMORS
Kathleen Neville
Favorite
Ng, Cedric Chuan-Young

National Cancer Centre Singapore
(P 285) TUMOUR-INFILTRATING MAST CELLS IN ANGIOSARCOMAS CORRELATE WITH CLINCIAL PHENOTYPES AND IMMUNO-ONCOLOGY PATHWAYS
Cedric Chuan-Young Ng
Favorite
Ng, Gillian

Laboratory of Applied Human Genetics, Division of Medical Sciences, National Cancer Centre Singapore
(P 336) EVOLUTION AND PURSUIT OF EXCELLENCE IN SARCOMA MANAGEMENT IN AN ASIAN TERTIARY SARCOMA SPECIALISED CENTRE
Gillian Ng
Favorite
Ng, Patrick

The Jackson Laboratory for Genomic Medicine
(P 392) IMMUNOSUPPRESSIVE TUMOR MICROENVIRONMENT OF OSTEOSARCOMA
Patrick Ng
Favorite
Nguyen, Buo-Phuc

University Hospital Essen, Sarcoma Centre
(P 47) PATIENT SURVIVAL IN METASTATIC GIST WITH IMATINIB-SENSITIVE MUTATIONS: REAL WORLD DATA FROM GERMAN REFERRAL CENTER (2008-2021)
Buo-Phuc Nguyen
Favorite
Nguyen, Dao

Sylvester Comprehensive Cancer Center
(P 461) OUTCOMES FOR OLIGOMETASTATIC PULMONARY DISEASE RECURRENCE TREATED WITH SURGERY ALONE FOR PATIENTS WITH SOFT TISSUE SARCOMAS A CASE SERIES
Dao Nguyen
Favorite
Nguyen, Ferro

Children’s Hospital of Philadelphia
(P 565) AN EARLY PHASE STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PRELIMINARY ANTITUMOR ACTIVITY OF PEEL-224 IN PATIENTS WITH ADVANCED SOLID TUMORS
Ferro Nguyen
Favorite
Nguyen, Sang

Vanderbilt University Medical Center
(P 211) AN ANALYSIS OF SELF-REPORTED DEPRESSION IN SARCOMA PATIENTS
Sang Nguyen
Favorite
Nica, Luminita

BC Cancer
(P 22) RECALL EXPERIENCE FOR SURVIVORS OF PEDIATRIC RHABDOMYOSARCOMA TREATED AT A SINGLE INSTITUTION BETWEEN 1970 AND 2010
Luminita Nica
Favorite
Nicholls, Audrey

Vanderbilt University Medical Center
(P 218) NEOADJUVANT CHEMOTHERPAY AND RADIATION DECREASES TUMOR SIZE, VIABILITY, AND RECURRENCE IN MULTIPLE LIPOSARCOMA SUBSETS
Audrey Nicholls
Favorite
Nielsen, Torsten

Department of Pathology and Laboratory Medicine, University of British Columbia
(P 267) NEW MOUSE MODEL OF SYNOVIAL SARCOMA BASED ON CONDITIONAL EXPRESSION IN MESENCHYMAL PROGENITORS
Torsten Nielsen
Favorite
(P 362) IDENTIFICATION OF A NOVEL INTERACTOR OF ENDOGENOUS SS18-SSX THROUGH MASS SPECTOMETRY-BASED ANALYSIS IN SYNOVIAL SARCOMA CELLS
Torsten Nielsen
Favorite
Niessen, Wiro

University of Groningen
(P 231) MINIMALLY INTERACTIVE SEGMENTATION OF SOFT-TISSUE TUMORS ON MRI AND CT USING DEEP LEARNING
Wiro Niessen
Favorite
(P 233) MULTI-CENTER EXTERNAL VALIDATION OF AN AUTOMATED MODEL DIFFERENTIATING ALT FROM LIPOMA USING RADIOMICS AND DEEP-LEARNING BASED SEGMENTATION
Wiro Niessen
Favorite
Nilsson, Jenny

Lund University
(P 371) DISRUPTION OF THE TP53 LOCUS IN OSTEOSARCOMA LEADS TO TP53 PROMOTER GENE FUSIONS AND RESTORATION OF PARTS OF THE TP53 SIGNALLING PATHWAY
Jenny Nilsson
Favorite
(P 372) COPY NUMBER GAIN OF MDM2 IN ROD-SHAPED CHROMOSOMES PROVIDES CLUES TO EARLY STAGES IN CIRCULARIZED GENE AMPLIFICATION IN LIPOSARCOMA
Jenny Nilsson
Favorite
Nishida, Yoshihiro

Nagoya University Hospital
(P 163) SELUMETINIB IN JAPANESE PEDIATRIC PATIENTS WITH SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA IN NEUROFIBROMATOSIS TYPE 1
Yoshihiro Nishida
Favorite
(P 396) COMPREHENSIVE WHOLE-GENOME MOLECULAR PROFILING IN BONE AND SOFT TISSUE SARCOMA: MULTI-OMICS ANALYSIS OF 627 CASES ACROSS HISTOLOGIC SUBTYPES
Yoshihiro Nishida
Favorite
Nishikawa, Tadaaki

National Cancer Center Hospital
(P 10) ATEZOLIZUMAB IN JAPANESE PATIENTS WITH ADVANCED ALVEOLAR SOFT PART SARCOMA: A MULTI-CENTER, SINGLE-ARM, INVESTIGATOR-INITIATED PHASE 2 TRIAL (NCCH1907)
Tadaaki Nishikawa
Favorite
Niu, Xiaohui

Department of Orthopaedic Oncology Surgery, Beijing Ji Shui Tan Hospital
(P 168) A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF PEXIDARTINIB IN ASIAN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR
Xiaohui Niu
Favorite
(P 169) UPDATED EFFICACY AND SAFETY PROFILE OF PIMICOTINIB (ABSK021) IN TENOSYNOVIAL GIANT CELL TUMOR (TGCT): 1-YEAR FOLLOW-UP FROM PHASE 1B
Xiaohui Niu
Favorite
(P 543) MANEUVER STUDY: A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF PIMICOTINIB (ABSK021) TO ASSESS THE EFFICACY AND SAFETY IN PATIENTS WITH TENOSYNOVIAL GIANT CELL TUMOR
Xiaohui Niu
Favorite
Nomie, Krystle

BostonGene, Corp.
(P 420) COMPREHENSIVE MOLECULAR PROFILING AND TUMOR MICROENVIRONMENT CHARACTERISTICS OF RADIATION-INDUCED SARCOMA.
Krystle Nomie
Favorite
Nomikos, Julia

Lunenfeld-Tanenbaum Research Institute - Mount Sinai Hospital
(P 108) EFFECT OF TUMOUR-TARGETED HYPERTHERMIA AND CHEMOTHERAPY ON THE IMMUNE PROFILE OF A MURINE MODEL OF EMBRYONAL RHABDOMYOSARCOMA
Julia Nomikos
Favorite
Nonobe, Norie

Nagoya University Hospital
(P 163) SELUMETINIB IN JAPANESE PEDIATRIC PATIENTS WITH SYMPTOMATIC INOPERABLE PLEXIFORM NEUROFIBROMA IN NEUROFIBROMATOSIS TYPE 1
Norie Nonobe
Favorite
Noonan, Sinead

CUH
(P 213) EXPERIENCE WITH THE USE OF TRABECTEDIN IN ADVANCED SOFT TISSUE SARCOMA IN IRELAND
Sinead Noonan
Favorite
Norenberg, Ricarda

Chrestos Concept GmbH & Co. KG
(P 161) EFFICACY, SAFETY, AND TREATMENT HOLD WAIT-AND-SEE OUTCOMES OF LAROTRECTINIB IN PEDIATRIC PATIENTS WITH TRK FUSION SARCOMAS
Ricarda Norenberg
Favorite
(P 353) UPDATED EFFICACY AND SAFETY OF LAROTRECTINIB IN ADULT PATIENTS WITH TRK FUSION SARCOMAS
Ricarda Norenberg
Favorite
(P 550) ON-TRK: A NON-INTERVENTIONAL STUDY OF LAROTRECTINIB IN PATIENTS WITH TRK FUSION SOLID TUMORS
Ricarda Norenberg
Favorite
Norris, Madelaine

The Ohio State University
(P 347) INCIDENCE AND TIMING OF RECURRENCE AFTER ADJUVANT PALBOCICLIB IN COMPLETELY RESECTED RETROPERITONEAL LIPOSARCOMA
Madelaine Norris
Favorite
Noujaim, Jonathan

Hôpital Maisonneuve-Rosemont and McGill University Health Center
(P 114) PRIMARY ANALYSIS OF EFFICACY AND SAFETY OF LETETRESGENE AUTOLEUCEL (LETE-CEL) AS FIRST-LINE TREATMENT FOR UNRESECTABLE OR METASTATIC SYNOVIAL SARCOMA (SS); SUBSTUDY 1 OF IGNYTE-ESO
Jonathan Noujaim
Favorite
Novello, Silvia

Department of Oncology, San Luigi Hospital, University of Turin
(P 109) INTENSE PRECLINICAL ACTIVITY BY B7H3-SPECIFIC CAR.CIK LYMPHOCYTES AGAINST EPITHELIOID SARCOMA
Silvia Novello
Favorite
(P 550) ON-TRK: A NON-INTERVENTIONAL STUDY OF LAROTRECTINIB IN PATIENTS WITH TRK FUSION SOLID TUMORS
Silvia Novello
Favorite
Novotny, Jan Philipp

University of Heidelberg
(P 541) ETCTN 10563: PHASE 1 STUDY OF PEPOSERTIB AND LIPOSOMAL DOXORUBICIN FOR ADVANCED OR METASTATIC LEIOMYOSARCOMA AND OTHER SARCOMAS
Jan Philipp Novotny
Favorite
Nozzoli, Filippo

Histopathology and Molecular Diagnostics, Careggi University Hospital Florence, Italy
(P 455) EXTRASKELETAL EWING SARCOMA: A MULTICENTRIC RETROSPECTIVE STUDY FROM THE ITALIAN SARCOMA GROUP
Filippo Nozzoli
Favorite
Nunez, Claudia

Hospital de la Santa Creu i Sant Pau
(P 503) SCAPULAR PROSTHESIS RECONSTRUCTION, EXPERIENCE IN OUR INSTITUTION
Claudia Nunez
Favorite
(P 504) WHY DO SOME PATIENTS WITH SYNOVIAL SARCOMA HAVE BETTER FUNCTIONAL OUTCOMES AFTER RESECTION SURGERY? ANALYSIS OF 102 CASES
Claudia Nunez
Favorite
(P 507) PRIMARY CHEST WALL TUMORS OF MESENCHYMAL ORIGIN. EXPERIENCE OF A REFERENCE UNIT
Claudia Nunez
Favorite
Nunez, Osvaldo

University of Miami Miller School of Medicine
(P 225) PAN-SARCOMA DATABASE (PSDB): A MODEL-VIEW-CONTROLLER FRAMEWORK UTILIZING REDCAP, SHINY, AND R TO CREATE A CONTINUOUS PIPELINE OF SARCOMA DATA
Osvaldo Nunez
Favorite
(P 226) SIGNATERA TESTING TO IDENTIFY MINIMAL RESIDUAL DISEASE IN HIGH GRADE SARCOMA
Osvaldo Nunez
Favorite
(P 366) SURVIVAL DISPARITIES IN HISPANIC PATIENTS WITH SARCOMA TESTED WITH NEXT-GENERATION SEQUENCING (NGS)
Osvaldo Nunez
Favorite
Nur, Samira

UCL cancer Institute
(P 381) THE GENOMIC LANDSCAPE OF CLEAR CELL SARCOMA
Samira Nur
Favorite
Nystrom, Lukas

Cleveland Clinic
(P 242) WHOLE BODY PET/MRI FOR STAGING OF MYXOID LIPOSARCOMA
Lukas Nystrom
Favorite
(P 402) TISSUE PERFUSION AND WOUND HEALING AFTER SOFT TISSUE SARCOMA RESECTION
Lukas Nystrom
Favorite
(P 513) THE IMPACT OF MARGIN STATUS ON THE ONCOLOGIC OUTCOMES OF SURGICALLY TREATED DEDIFFERENTIATED LIPOSARCOMA OF THE EXTREMITIES
Lukas Nystrom
Favorite
(P 514) INTERSTITIAL BRACHYTHERAPY IN THE TREATMENT OF SOFT TISSUE SARCOMA: LOCAL RECURRENCE AND WOUND OUTCOMES
Lukas Nystrom
Favorite